4//SEC Filing
Hattersley Gary 4
Accession 0001521111-25-000003
CIK 0001811063other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:24 PM ET
Size
13.6 KB
Accession
0001521111-25-000003
Insider Transaction Report
Form 4
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Class A Common Stock
2025-10-27$5.02/sh−100,000$502,460→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-27−100,000→ 298,935 totalExercise: $1.74Exp: 2030-01-21→ Class A Common Stock (100,000 underlying) - Exercise/Conversion
Class A Common Stock
2025-10-27$1.74/sh+100,000$174,000→ 100,000 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan dated June 24, 2024.
- [F2]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years.
Documents
Issuer
Nuvation Bio Inc.
CIK 0001811063
Entity typeother
Related Parties
1- filerCIK 0001521111
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:24 PM ET
- Size
- 13.6 KB